Inverness To Pay $110M For Kroll Drug Testing Unit

Law360, New York (February 4, 2010, 5:03 PM EST) -- Medical diagnostic test maker Inverness Medical Innovations Inc. announced Thursday that it will take on the substance abuse testing division of Kroll Inc. in an all-cash deal valued at $110 million.

Kroll Laboratory Specialists Inc. specializes in forensic-quality substance abuse testing products and services used by employers, occupational health providers, third-party administrators, criminal justice authorities and government institutions around the U.S.

All of the Kroll substance abuse tests and services are licensed by the U.S. Substance Abuse and Mental Health Services Administration, the industry benchmark, Inverness...
To view the full article, register now.